Robert Moses
Follow
Get notifications in MyBN when activity occurs.
Robert Moses
Robert Moses has over 40 years of experience in the pharmaceutical and biotechnology industry.
Prior to becoming the corporate vice president of CSL for 4 years, Mr Moses was the managing director of Freehills, chair and chief executive of NASDAQ-listed medical service company, and corporate manager of new business development at ICI (now Orica). He had also spent 17 years in various management roles at Eli Lilly.
Prior to becoming the corporate vice president of CSL for 4 years, Mr Moses was the managing director of Freehills, chair and chief executive of NASDAQ-listed medical service company, and corporate manager of new business development at ICI (now Orica). He had also spent 17 years in various management roles at Eli Lilly.
Lists and Charts
Share Transactions
Total value as at the date of the transaction
Powered by Morningstar ®
Revenue
| Rank | Company | Revenue | |
|---|---|---|---|
| 969th |  | Antisense Therapeutics | $1.6m |
1333 listed non wa companies ranked by revenue.
Powered by Morningstar ®
Powered by Morningstar ®
Person Activity
 | NEW ROLE: Non-Executive Director, was Chair 2001-2021, Antisense Therapeutics | 03 Nov 2020 |
Related Information
Positions - Previous
| Position | Company | Year | Company's current rank |
|---|---|---|---|
| Non-Executive Director, was Chair 2001-2021 | | 2001 - 2021 | 969 |
Directors Interests
| Company | Date | Transaction type | Number of shares | Price per share | Transaction value | Nature of change |
|---|---|---|---|---|---|---|
| Antisense Therapeutics | 03 Dec 2020 | Issued | 90,201 | $0.10 | $9,020 | OtherParticipation in share purchase plan |
Powered by Morningstar ®
